HELLP syndrome - A multisystemic disorder

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 4, 2007, Pages 419-424

  Mihu, Dan ^a,b   Costin, Nicolae ^a   Mihu, Carmen Mihaela ^a   Seicean, Andrada ^a   Ciortea, Rǎzvan ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinic of Obstetrics Gynecology   (Romania)

Author keywords

Diagnosis; HELLP syndrome; Liver hematoma; Preeclampsia; Pregnancy; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANTICOAGULANT AGENT; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; D DIMER; HAPTOGLOBIN; HEPARIN; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; PLASMA SUBSTITUTE; PROSTACYCLIN;

AEROBIC METABOLISM; BLOOD TRANSFUSION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL DYSFUNCTION; FATTY ACID METABOLISM; FETOPLACENTAL UNIT; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INCIDENCE; INTENSIVE CARE UNIT; LAPAROTOMY; LIVER HEMATOMA; LOW DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PROGNOSIS; PROTHROMBIN TIME; REVIEW; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HELLP SYNDROME; HUMANS; LIVER; PREGNANCY; PREVALENCE; PROGNOSIS;

EID: 37549069932     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103: 981-991.
2. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. QJM 2002; 95: 343-357.
3. Isler CM, Rinehart BK, Terrone DA, May WL, Magann EF, Martin JN Jr. The importance of parity to major maternal morbidity in the eclamptic mother with HELLP syndrome. Hypertens Pregnancy 2003; 22: 287-294.
4. Sibai BM, Caritis S, Hauth J, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about preeclampsia. Semin Perinatol 2003; 27: 239-246.
5. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 2003; 188: 473-479.
6. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004; 286: H1389-1393.
7. Araujo AC, Leao MD, Nobrega MH, et al. Characteristics and treatment of hepatic rupture caused by HELLP syndrome. Am J Obstet Gynecol 2006; 195: 129-133.
8. Kam PC, Thompson SA, Liew AC. Thrombocytopenia in the parturient. Anaesthesia 2004; 59: 255-264.
9. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160: 1405-1423.
10. Hulstein JJ, van Runnard Heimel PJ, Franx A, et al. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost 2006; 4: 2569-2575.
11. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-2512.
12. Holub M, Bodamer OA, Item C, Mühl A, Pollak A, Stöckler- Ipsiroglu S. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatr 2005; 94: 48-52.
13. Yang Z, Yamada J, Zhao Y,Strauss AW, Ibdah JA. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002; 288: 2163-2166.
14. Noris M, Todeschini M, Cassis P, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004; 43: 614-622.
15. Kawabata I, Nakai A, Takeshita T. Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound. Arch Gynecol Obstet 2006; 274: 303-309.
16. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
17. Wicke C, Pereira PL, Neeser E, Flesch I, Rodegerdts EA, Becker HD. Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options- a unicenter study. Am J Obstet Gynecol 2004; 190: 106-112.
18. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-1006.
19. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 2007; 86: 648-651.
20. Gutierez Cruz O, Careaga Benitez R. Diabetes insipidus and pregnancy. Ginecol Obstet Mex 2007; 75: 224-229.
21. Veres K, Papp K, Lakos G, et al. Association of HELLP syndrome with primary antiphospholipid syndrome-a case report. Clin Rheumatol 2007 Aug 8; Epub ahead of print.
22. Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007; 9: 219-225.
23. Gomez-Puerta JA, Cervera R, Espinosa G, et al. Catastrophic antiphospholipid syndrome during pregnancy and Puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 2007; 66: 740-746.
24. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404.
25. O'Brien J, Buckley O, Munk PL, Torreggiani WC. An unusual case of elevated liver enzymes (2006: 10b). Hepatic necrosis following HELLP syndrome. Eur Radiol 2007; 17: 289-291.
26. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-880.
27. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22: 203-212.
28. Heitner JC, Koy C, Kreutzer M, Gerber B, Reimer T, Glocker MO. Differentiation of HELLP patients from healthy pregnant women by proteome analysis - on the way towards a clinical marker set. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 840: 10-19.
29. Maher MM, Kalra MK, Lucey BC, et al. Haemolysis, elevated liver enzymes and low platelets syndrome: ultrasound and magnetic resonance imaging findings in the liver. Australas Radiol 2004; 48: 64-68.
30. Nunes JO, Turner MA, Fulcher AS. Abdominal imaging features of HELLP syndrome: a 10-year retrospective review. AJR Am J Roentgenol 2005; 185: 1205-1210.
31. Juárez-Azpilcueta A, Motta-Martínez E, Montańo- Uzcanga A. Hepatic Rupture as a Complication of Hypertensive Disease of Pregnancy Maternal and the HELLP Syndrome. Gac Med Mex 2003; 139: 276-280.
32. Knopp U, Kehler U, Rickmann H, Arnold H, Gliemroth J. Cerebral haemodynamic pathologies in HELLP syndrome. Clin Neurol Neurosurg 2003; 105: 256-261.
33. Ellidokuz E, Uslan I, Demir S, Cevrioglu S, Tufan G. Transient postpartum diabetes insipidus associated with HELLP syndrome. J Obstet Gynaecol Res 2006; 32: 602-604.
34. Yamanaka Y, Takeuchi K, Konda E, et al. Transient postpartum diabetes insipidus in twin pregnancy associated with HELLP syndrome. J Perinat Med 2002; 30: 273-275.
35. Mallick IH, Syed SA, Kar AK. Liver rupture following delivery: HELLP needed. Emerg Med J 2007; 24: 372.
36. Pliego Pérez AR, Zavala Soto JO, Rodríguez Ballesteros R, Martínez Herrera Fde J, Porras Jiménez A. Spontaneous hepatic rupture of pregnancy. A report of four cases and medical literature review. Ginecol Obstet Mex 2006; 74: 224-231.
37. Seren G, Morel J, Jospe R, et al. HELLP syndrome and ruptured subcapsular hepatic haematoma. Case report and therapeutic options. Ann Fr Anesth Reanim 2006; 25: 1067-1069.
38. Tsirigotis P, Mantzios G, Pappa V, et al. Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome. Rheumatol Int 2007; Jun 19; Epub ahead of print.
39. Carlson KL, Bader CL. Ruptured subcapsular liver hematoma in pregnancy: a case report of nonsurgical management. Am J Obstet Gynecol 2004; 190: 558-560.
40. Isler CM, Barrillcaux PS, Magann EF, Bass JD, Martin JN Jr. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001; 184: 1332-1337.
41. Martin JN Jr, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003; 189: 830-834.
42. Hincz P, Bielak A, Borowski D, et al. The use of steroids in the treatment of HELLP syndrome - case report. Ginekol Pol 2007; 78: 245-247.
43. Matchaba C, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2004; CD 002076.
44. Vidaeff AC, Yeomans ER. Corticosteroids for the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): what evidence? Minerva Ginecol 2007; 59: 183-190.
45. Eser B, Guven M, Unal A, et al. The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 2005; 11: 211-217.
46. Bayraktaroqlu Z, Demirci F, Balat O, Kutlar I, Okan V, UCrossed d signur G. Plasma exchange therapy in HELLP syndrome: A single-center experience. Turk J Gastroenterol 2006; 17: 99-102.
47. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003; 101: 217-220.
48. Thomas T, Jophy R, Mhaskar A, Misguith D. Are we increasing serious maternal morbidity by postponing termination of pregnancy in severe pre-eclampsia/eclampsia? J Obstet Gynaecol 2005; 25: 347-351.
49. Harris BM, Kuczkowski KM. Diagnostic dilemma: hepatic rupture due to HELLP syndrome vs. trauma. Arch Gynecol Obstet 2005; 272: 176-178.
50. Polley LS. Anesthetic management of hypertension in pregnancy. Clin Obstet Gynecol 2003; 46: 688-699.
51. Suzuki T, Kaneda T. Anesthesia in three women with HELLP syndrome. Masui 2007; 56: 838-841.
52. Szafranko K, Tymińska M, Borucnki W. HELLP syndrome complicated by liver rupture. Ginekol Pol 2005; 76: 910-912.
53. Marsh FA, Kaufmann SJ, Bhabra K. Surviving hepatic rupture in pregnancy - a literature review with an illustrative case report. J Obstet Gynaecol 2003; 23: 109-113.
54. Wüst MD, Bolte AC, de Vries JI, et al. Pregnancy outcome after previous pregnancy complicated by hepatic rupture. Hypertens Pregnancy 2004; 23: 29-35.
55. Shrivastova VK, Imagawa D, Wing DA. Argon beam coagulator for treatment of hepatic rupture with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. Obstet Gynecol 2006; 107: 525-526.
56. Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP. Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 2004; 103: 1055-1058.
57. Dart BW 4th, Cockerham WT, Torres C, Kipikasa JH, Maxwell RA. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma 2004; 57: 171-174.
58. Shames BD, Fernandez LA, Sollinger HW, et al. Liver transplantation for HELLP syndrome. Liver Transpl 2005; 11: 224-228.